HRTS vs. PBPH

Last updated Jun 24, 2026

HRTS (Tema Obesity & Cardiometabolic ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds. HRTS is actively managed, while PBPH is passively managed. Their correlation of 0.91 suggests significant overlap in exposure. HRTS charges 0.75%/yr vs 0.13%/yr for PBPH.

Performance

HRTS vs. PBPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema Obesity & Cardiometabolic ETF (HRTS) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HRTS achieves a -1.45% return, which is significantly lower than PBPH's 2.63% return.

HRTS

• 1D: 1.50%
• 1M: 1.21%
• YTD: -1.45%
• 6M: -2.09%
• 1Y: 25.88%
• 3Y*: —
• 5Y*: —
• 10Y*: —

PBPH

• 1D: 1.41%
• 1M: 0.87%
• YTD: 2.63%
• 6M: 2.11%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HRTS vs. PBPH - Yearly Performance Comparison

	2026 (YTD)	2025
HRTS Tema Obesity & Cardiometabolic ETF	-1.45%	1.99%
PBPH Portfolio Building Block World Pharma and Biotech Index ETF	2.63%	0.74%

Correlation

The correlation between HRTS and PBPH is 0.91, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (All Time) Calculated using the full available price history since Nov 25, 2025	0.91

Return for Risk

HRTS vs. PBPH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HRTS

HRTS Risk / Return Rank: 48
HRTS Sharpe Ratio Rank: 49
HRTS Sortino Ratio Rank: 54
HRTS Omega Ratio Rank: 46
HRTS Calmar Ratio Rank: 51
HRTS Martin Ratio Rank: 39

PBPH

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HRTS vs. PBPH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema Obesity & Cardiometabolic ETF (HRTS) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	HRTS	PBPH	Difference
Sharpe ratio: Return per unit of total volatility	1.60	—	—
Sortino ratio: Return per unit of downside risk	2.42	—	—
Omega ratio: Gain probability vs. loss probability	1.27	—	—
Calmar ratio: Return relative to maximum drawdown	2.36	—	—
Martin ratio: Return relative to average drawdown	5.70	—	—

Drawdowns

HRTS vs. PBPH - Drawdown Comparison

The maximum HRTS drawdown since its inception was -25.81%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for HRTS and PBPH.

Drawdown Indicators

	HRTS	PBPH	Difference
Max Drawdown Largest peak-to-trough decline	-25.81%	-11.10%	-14.71%
Max Drawdown (1Y) Largest decline over 1 year	-11.01%	—	—
Current Drawdown Current decline from peak	-5.04%	-5.21%	+0.17%
Average Drawdown Average peak-to-trough decline	-8.96%	-4.36%	-4.60%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.55%	—	—

Volatility

Volatility by Period

	HRTS	PBPH	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.41%	—	—
Volatility (6M) Calculated over the trailing 6-month period	11.72%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	16.22%	17.07%	-0.85%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.08%	17.07%	+2.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.08%	17.07%	+2.01%

HRTS vs. PBPH - Expense Ratio Comparison

HRTS has a 0.75% expense ratio, which is higher than PBPH's 0.13% expense ratio.

Dividends

HRTS vs. PBPH - Dividend Comparison

HRTS's dividend yield for the trailing twelve months is around 1.36%, more than PBPH's 0.09% yield.

Position	TTM	2025	2024
HRTS Tema Obesity & Cardiometabolic ETF	1.36%	1.34%	1.63%
PBPH Portfolio Building Block World Pharma and Biotech Index ETF	0.09%	0.09%	0.00%

Frequently Asked Questions

Can I hold both HRTS and PBPH in my portfolio?

With a correlation of 0.91, HRTS and PBPH move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.

Which ETF is better, HRTS or PBPH?

On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, HRTS or PBPH?

PBPH is cheaper with a 0.13% expense ratio, compared with 0.75% for HRTS.

Which ETF pays a higher dividend yield, HRTS or PBPH?

HRTS has the higher dividend yield at 1.36%, compared with 0.09% for PBPH.

What is the main difference between HRTS and PBPH?

They also come from different issuers: Tema and Portfolio Building Block. Their fees differ too: 0.75% for HRTS and 0.13% for PBPH.